Who founded NovoCure?

NovoCure was founded by Yoram Palti in 2000.

Who are NovoCure's investors?

NovoCure's investors include Pfizer Venture Investments, Windham Capital Partners.

NovoCure

NASDAQ: NVCR

Founded 2000 · 1,504 employees on LinkedIn · 2 known investors

Find your way into NovoCure

Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.

Biotech Healthtech Medical Devices

Founders & leadership

NovoCure was founded in 2000 by Yoram Palti.

Yoram PaltiFounder, CTO

William F. DoyleExecutive Chairman

Frank LeonardChief Executive Officer

Investors · 2

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us

Windham Capital Partnerslisted by Windham Capital PartnersNew York · $1M – $5M

Competitors · 2

by search overlap

Onkure Therapeutics Inc41 shared keywordsOnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.

NextCure37 shared keywordsNextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.

Companies competing with NovoCure for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does NovoCure do?: Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
Who founded NovoCure?: NovoCure was founded by Yoram Palti in 2000.
Who are NovoCure's investors?: NovoCure's investors include Pfizer Venture Investments, Windham Capital Partners.